Essential Partners’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
RCMNY
ACM
PAI
Essential Partners's PRTA Position: Q2 2026 in Review
Essential Partners reduced its Prothena Corp (PRTA) stake by 25% in Q2 2026, selling an estimated $810 and leaving 251 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1891.
Essential Partners first reported a position in PRTA in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.25K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.
- Essential Partners held 251 shares of Prothena Corp worth $2.46K as of Q2 2026.
- Essential Partners sold 82 Prothena Corp shares in Q2 2026, an estimated $810.
- Prothena Corp made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1891 holding.
- Essential Partners first reported a position in Prothena Corp in Q3 2025 and has held it in 4 quarters since.
- Essential Partners's Prothena Corp position peaked at $3.25K in Q3 2025.
- 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.
Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.